Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations
暂无分享,去创建一个
W. Klapper | R. Siebert | B. Burkhardt | A. Traulsen | C. Pott | M. Szczepanowski | P. Kluin | I. Nagel | Sietse M. Aukema | A. Claviez | M. Rohde | J. Bradtke | I. Oschlies | Benedikt Bauer | S. Gattenlöhner | B. R. Bonn | E. M. Murga Penas | Laura Theil | O. Makarova | S. Aukema | Bettina R. Bonn
[1] G. Leverger,et al. Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective “Lymphomes Malins B” protocols. A Société Française des Cancers de l’Enfant study , 2015, Haematologica.
[2] K. Basso,et al. Germinal centres and B cell lymphomagenesis , 2015, Nature Reviews Immunology.
[3] K. Ando,et al. A case of clonally distinct relapse of Burkitt lymphoma 9 years after complete remission , 2015, International Journal of Hematology.
[4] Peter Martin,et al. Deep sequencing reveals clonal evolution patterns and mutation events associated with relapse in B-cell lymphomas , 2014, Genome Biology.
[5] T. Liehr,et al. Conventional and molecular cytogenetic characterization of Burkitt lymphoma with bone marrow involvement in Brazilian children and adolescents , 2014 .
[6] W. Klapper,et al. Genomic and epigenomic co-evolution in follicular lymphomas , 2014, Leukemia.
[7] C. Bokemeyer,et al. Comprehensive cytogenetic and molecular cytogenetic analysis of 44 Burkitt lymphoma cell lines: Secondary chromosomal changes characterization, karyotypic evolution, and comparison with primary samples , 2014, Genes, chromosomes & cancer.
[8] P. Kluin. The missing link in early follicular lymphoma development. , 2014, Blood.
[9] B. Nadel,et al. Human t(14;18)positive germinal center B cells: a new step in follicular lymphoma pathogenesis? , 2014, Blood.
[10] B. Nadel,et al. Nature and importance of follicular lymphoma precursors , 2014, Haematologica.
[11] O. Griffith,et al. Mitelman Database (Chromosome Aberrations and Gene Fusions in Cancer) , 2014 .
[12] R. Spang,et al. Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma , 2014, Haematologica.
[13] J. Nguyen,et al. Analysis of Immunoglobulin Heavy Chain Rearrangement in a Child With Recurrent Burkitt Lymphoma to Determine Clonality , 2014, Journal of pediatric hematology/oncology.
[14] Raul Rabadan,et al. Genetics of follicular lymphoma transformation. , 2014, Cell reports.
[15] M. Calaminici,et al. Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma , 2013, Nature Genetics.
[16] Raul Rabadan,et al. Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia. , 2013, Blood.
[17] F. Mitelman,et al. Mitelman database of chromosome aberrations and gene fusions in cancer , 2014 .
[18] S. Carter,et al. Clonal evolution in hematological malignancies and therapeutic implications , 2014, Leukemia.
[19] E. Kjeldsen,et al. Supernumerary Isochromosome 1, idic(1)(p12), Leading to Tetrasomy 1q in Burkitt Lymphoma , 2013, Cytogenetic and Genome Research.
[20] Raffaella Casadei,et al. An estimation of the number of cells in the human body , 2013, Annals of human biology.
[21] Krishnendu Chatterjee,et al. Evolutionary dynamics of cancer in response to targeted combination therapy , 2013, eLife.
[22] W. Woessmann. XI. How to treat children and adolescents with relapsed non‐Hodgkin lymphoma? , 2013, Hematological oncology.
[23] S. Swerdlow,et al. Double-hit B-cell Lymphomas With BCL6 and MYC Translocations Are Aggressive, Frequently Extranodal Lymphomas Distinct From BCL2 Double-hit B-cell Lymphomas , 2013, The American journal of surgical pathology.
[24] Giovanni Parmigiani,et al. Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation , 2013, Proceedings of the National Academy of Sciences.
[25] A. Hagemeijer,et al. Patterns of genomic aberrations suggest that Burkitt lymphomas with complex karyotype are distinct from other aggressive B‐cell lymphomas with MYC rearrangement , 2013, Genes, chromosomes & cancer.
[26] Ash A. Alizadeh,et al. Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. , 2012, Blood.
[27] R. Spang,et al. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing , 2012, Nature Genetics.
[28] Dereje D. Jima,et al. The genetic landscape of mutations in Burkitt lymphoma , 2012, Nature Genetics.
[29] L. Staudt,et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics , 2012, Nature.
[30] M. Nussenzweig,et al. Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas. , 2012, Blood.
[31] Michael Meyer-Hermann,et al. A theory of germinal center B cell selection, division, and exit. , 2012, Cell reports.
[32] R. Miles,et al. Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia , 2012, British journal of haematology.
[33] D. Linch,et al. Burkitt lymphoma in adults , 2012, British journal of haematology.
[34] R. Siebert,et al. The gray zone between Burkitt's lymphoma and diffuse large B-cell lymphoma from a genetics perspective. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] P. Krapivsky,et al. Exact solution of a two-type branching process: models of tumor progression , 2011, 1105.1157.
[36] A. Cherry,et al. A pediatric B lineage leukemia with coincident MYC and MLL translocations. , 2011, Journal of pediatric hematology/oncology.
[37] Philip M Kluin,et al. Double-hit B-cell lymphomas. , 2011, Blood.
[38] W. Klapper,et al. Non-Hodgkin's lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols , 2011, Leukemia.
[39] R. Spang,et al. Detection of genomic aberrations in molecularly defined Burkitt’s lymphoma by array-based, high resolution, single nucleotide polymorphism analysis , 2010, Haematologica.
[40] T. Wirth,et al. Advances in the understanding of MYC‐induced lymphomagenesis , 2010, British journal of haematology.
[41] N. Karandikar,et al. Simple karyotype and bcl-6 expression predict a diagnosis of Burkitt lymphoma and better survival in IG-MYC rearranged high-grade B-cell lymphomas , 2010, Modern Pathology.
[42] R. Durrett,et al. Evolutionary dynamics of tumor progression with random fitness values. , 2010, Theoretical population biology.
[43] W. Sanger,et al. An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children’s Oncology Group study CCG‐5961 , 2010, British journal of haematology.
[44] H. Ohtsuki,et al. Accumulation of driver and passenger mutations during tumor progression , 2009, Proceedings of the National Academy of Sciences.
[45] G. Klein,et al. To the genesis of Burkitt lymphoma: regulation of apoptosis by EBNA-1 and SAP may determine the fate of Ig-myc translocation carrying B lymphocytes. , 2009, Seminars in cancer biology.
[46] R. Gascoyne,et al. Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. , 2009, Blood.
[47] W. Sanger,et al. Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell Non-Hodgkin’s Lymphoma: Results of the FAB/LMB 96 international study , 2008, Leukemia.
[48] R. Siebert,et al. Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge , 2008, Leukemia.
[49] G. Klein,et al. Burkitt lymphoma. , 2005, Seminars in cancer biology.
[50] Myungshin Kim,et al. Burkitt lymphoma with dual translocation of chromosome 14: a novel chromosomal abnormality of t(8;14),t(14;15). , 2008, Annals of clinical and laboratory science.
[51] Carolyn J. Brown,et al. Prognostic significance of secondary cytogenetic alterations in follicular lymphomas , 2008, Genes, chromosomes & cancer.
[52] H. Avet-Loiseau. Reply to: [Comment to: The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement. Haematologica 2007; 92:1335-1342 , 2008, Haematologica.
[53] H. Tilly,et al. Comment to: The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement. Haematologica 2007; 92:1335-1342 , 2008, Haematologica.
[54] A. Rosenwald,et al. Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma , 2008, Oncogene.
[55] Riccardo Dalla-Favera,et al. Germinal centres: role in B-cell physiology and malignancy , 2008, Nature Reviews Immunology.
[56] Å. Borg,et al. Tiling resolution array comparative genomic hybridization, expression and methylation analyses of dup(1q) in Burkitt lymphomas and pediatric high hyperdiploid acute lymphoblastic leukemias reveal clustered near-centromeric breakpoints and overexpression of genes in 1q22-32.3. , 2007, Human molecular genetics.
[57] C. Larsson,et al. Genomic imbalances during transformation from follicular lymphoma to diffuse large B-cell lymphoma , 2007, Modern Pathology.
[58] S. Raimondi,et al. Secondary chromosomal abnormalities predict outcome in pediatric and adult high‐stage Burkitt lymphoma , 2006, Cancer.
[59] R. Spang,et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. , 2006, The New England journal of medicine.
[60] B. Burkhardt,et al. The impact of age and gender on biology, clinical features and treatment outcome of non‐Hodgkin lymphoma in childhood and adolescence , 2005, British journal of haematology.
[61] Bernhard Hiller,et al. CyDAS: a cytogenetic data analysis system , 2005, Bioinform..
[62] J. Walewski,et al. Frequent aberrations of chromosome 8 in aggressive B-cell non-Hodgkin lymphoma. , 2005, Cancer genetics and cytogenetics.
[63] P. Jagers,et al. Branching Processes: Variation, Growth, and Extinction of Populations , 2005 .
[64] P. Kluin,et al. Gender and age-related differences in Burkitt lymphoma--epidemiological and clinical data from The Netherlands. , 2004, European journal of cancer.
[65] W. Sanger,et al. Chromosome Abnormalities May Correlate With Prognosis in Burkitt/Burkitt-Like Lymphomas of Children and Adolescents: A Report From Children's Cancer Group Study CCG-E08 , 2004, Journal of pediatric hematology/oncology.
[66] C. Morris,et al. Telomeric association of chromosomes in B-cell lymphoid leukemia , 2004, Human Genetics.
[67] A. Borkhardt,et al. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis. , 2004, Haematologica.
[68] Shumei S. Guo,et al. 2000 CDC Growth Charts for the United States: methods and development. , 2002, Vital and health statistics. Series 11, Data from the National Health Survey.
[69] Martin J S Dyer,et al. Interphase FISH assays for the detection of translocations with breakpoints in immunoglobulin light chain loci , 2002, International journal of cancer.
[70] B. Johansson,et al. Cytogenetic and Molecular Genetic Evolution of Chronic Myeloid Leukemia , 2002, Acta Haematologica.
[71] Shumei S. Guo,et al. CDC GROWTH CHARTS FOR THE UNITED STATES: METHODS AND DEVELOPMENT 2000 , 2002 .
[72] Marek Kimmel,et al. Branching processes in biology , 2002 .
[73] G. Leverger,et al. Francaise d ' Oncologie Pediatrique LMB 89 protocol : highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L 3 leukemia , 2001 .
[74] C. R. Pinkerton,et al. Outcome of relapsed or refractory childhood B‐cell acute lymphoblastic leukaemia and B‐cell non‐Hodgkin's lymphoma treated with the UKCCSG 9003/9002 protocols , 2001, British journal of haematology.
[75] Garnett Kelsoe,et al. Predicted and inferred waiting times for key mutations in the germinal centre reaction: Evidence for stochasticity in selection , 1998, Immunology and cell biology.
[76] M. Narbaitz,et al. Variant (8;22) translocation in lymphoblastic lymphoma. , 1996, Leukemia & lymphoma.
[77] M. Fussenegger,et al. Cloning and characterization of the , 1996 .
[78] B. Johansson,et al. Cytogenetic evolution patterns in non-Hodgkin's lymphoma. , 1995, Blood.
[79] H. Kantarjian,et al. Adult acute lymphoblastic leukemia at relapse. Cytogenetic, immunophenotypic, and molecular changes , 1995, Cancer.
[80] J. Goedert,et al. Persistence of immunoglobulin heavy chain/c-myc recombination-positive lymphocyte clones in the blood of human immunodeficiency virus-infected homosexual men. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[81] S. Steinberg,et al. Sequential analysis of 43 patients with non-Hodgkin's lymphoma: clinical correlations with cytogenetic, histologic, immunophenotyping, and molecular studies. , 1995, Blood.
[82] J. M. García-Sagredo,et al. Burkitt lymphoma with a duplication of der(8)t(2;8). Interpretation of a complex karyotype by chromosome painting. , 1994, Cancer genetics and cytogenetics.
[83] H. Naito,et al. Jumping translocations of 1q in Burkitt lymphoma and acute nonlymphocytic leukemia. , 1993, Cancer genetics and cytogenetics.
[84] N. Heerema,et al. Cytogenetic analysis in relapsed childhood acute lymphoblastic leukemia. , 1992, Leukemia.
[85] D. de Jong,et al. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. , 1991, Oncogene.
[86] T. Takeda,et al. Karyotypic changes from initial diagnosis to relapse in childhood acute leukemia. , 1990, Leukemia.
[87] R. Berger,et al. Secondary nonrandom chromosomal abnormalities of band 13q34 in burkitt lymphoma‐leukemia , 1989, Genes, chromosomes & cancer.
[88] P. Fenaux,et al. Cytogenetic studies in 30 patients with Burkitt's lymphoma or L3 acute lymphoblastic leukemia with special reference to additional chromosome abnormalities. , 1989, Annales de genetique.
[89] E. Jaffe,et al. Development of a second clonally discrete Burkitt's lymphoma in a human immunodeficiency virus-positive homosexual patient. , 1988, Blood.
[90] G. Tricot,et al. Burkitt-type ALL with variant t(2;8) and complex additional rearrangements at diagnosis. , 1987, Annales de Genetique.
[91] K. Franssila,et al. Chromosome abnormalities in 16 Finnish patients with Burkitt's lymphoma or L3 acute lymphocytic leukemia. , 1984, Cancer genetics and cytogenetics.
[92] H. Ohno,et al. Karyotype evolution in B‐cell lymphoid malignancy with AN 8;14 translocation , 1983, International journal of cancer.
[93] R. Berger,et al. Cytogenetic studies on Burkitt's lymphoma-leukemia. , 1982, Cancer genetics and cytogenetics.
[94] E. Gelmann,et al. Cloning and characterization of different human sequences related to the onc gene (v-myc) of avian myelocytomatosis virus (MC29). , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[95] Y. Hayashi,et al. Burkitt's lymphoma with 2/8 translocation: a case report with special reference to the clinical features. , 1982, Cancer genetics and cytogenetics.
[96] L. Zech,et al. High‐resolution analysis of chromosome markers in burkitt lymphoma cell lines , 1982, International journal of cancer.
[97] K. Woo,et al. ANALYSIS OF THE PROLIFERATION KINETICS OF BURKITT'S LYMPHOMA CELLS , 1980, Cell and tissue kinetics.
[98] J. Whang‐Peng,et al. Cytogenetic studies in non-African Burkitt lymphoma. , 1980, Blood.
[99] Iscn. International System for Human Cytogenetic Nomenclature , 1978 .
[100] D. Gillespie. Exact Stochastic Simulation of Coupled Chemical Reactions , 1977 .
[101] W. J. Harrison. The total cellularity of the bone marrow in man , 1962, Journal of clinical pathology.